These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Treatment of POEMS syndrome with bevacizumab.
    Author: Samaras P, Bauer S, Stenner-Liewen F, Steiner R, Zweifel M, Renner C, Knuth A.
    Journal: Haematologica; 2007 Oct; 92(10):1438-9. PubMed ID: 18024383.
    Abstract:
    We report a case of POEMS syndrome which relapsed six years after autologous peripheral blood stem cell transplantation. According to encouraging data published recently, we treated the patient with cyclophosphamide, dexamethasone and the VEGF-antibody bevacizumab. After an initial improvement, the subsequent course was complicated by severe adverse events leading to multiorgan failure and death. This dramatic decline highlights the need for further investigation before using bevacizumab in patients with POEMS syndrome.
    [Abstract] [Full Text] [Related] [New Search]